Mediwound LTD Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
Samuel Rubinstein, a Director of MediWound Ltd., reported multiple transactions in common stock on September 1, 2026.
NASDAQ
Shmuel Hess, COO & Chief Commercial Officer of MediWound Ltd., sold 5,823 shares of common stock on August 26, 2026.
NASDAQ
MediWound Ltd. Director Nachum Shamir has acquired ordinary shares and holds various derivative securities, as detailed in a recent SEC Form 4 filing.
NASDAQ
MediWound Ltd. director David Morton Fox reported the acquisition of ordinary shares and the grant of stock options on June 1, 2026.
NASDAQ
MediWound Ltd. Director Samuel Rubinstein reported the acquisition of 150 ordinary shares and provided an update on his beneficial ownership of company stock.